コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ession at 3 hours also was 300% higher after CO treatment.
2 ; this interaction is superior after 24 h of CO treatment.
3 TGF-beta(2) treatment and inhibited by MG132 co-treatment.
4 d that stimulated by FGF-2 was observed with co-treatment.
5 lt + furosemide, but not with spironolactone co-treatment.
6 liver toxicity caused by bortezomib and LPS co-treatment.
7 ects, an effect markedly attenuated by L-NNA co-treatment.
8 ports continuing current recommendations for co-treatment.
9 eased by approximately 50% with beta-agonist co-treatment.
10 naling inhibitor and epidermal growth factor co-treatment.
11 tes and culture medium following lithium-VPA co-treatment.
12 oprotection induced by FGF-21 or lithium-VPA co-treatment.
13 ith or without 3 weeks prior and 3 weeks BF2 co-treatment.
14 in were significantly enhanced by LMB and IR co-treatment.
15 o IGF-IR was significantly attenuated by PRL co-treatment.
16 ular fumarate concentrations after metformin co-treatment.
17 the start of treatment; however, AI/estrogen co-treatment allowed for 90-100% survival and the mainte
18 e mice while pioglitazone and estradiol (E2) co-treatment ameliorated TFH cells and GC responses in m
19 er) undergoes structural rearrangement after CO treatment, and the observed changes help reconcile th
21 /24 h, respectively), whereas spironolactone co-treatment attenuated (p < 0.05) these incremental los
23 tic studies further revealed that all of the co-treatments containing ABT-869 resulted in decreased a
24 HHTx under short-course tacrolimus RESULTS: CO treatment (d0-28, 0-100) was remarkably effective in
26 , which induced DUSP1 expression, plus IL1B (co-treatment), DUSP1 expression was further enhanced.
27 d diseases (STDs) have recommended empirical co-treatment for chlamydia when patients are treated for
28 include once-daily dosing, simplification of co-treatment for tuberculosis, preservation of ritonavir
29 - 137 microg/24 h, respectively); furosemide co-treatment further increased (p < 0.05) urinary Ca2+ a
30 cytosolic NAD(+)/NADH ratio, whereas oleate co-treatment had the opposite effect on cellular redox.
31 inical trials testing Akt and EGFR inhibitor co-treatment in patients with elevated phospho-Akt level
32 urred in patients taking both ACEI and BB as co-treatment, in whom the decrease in LVIDd and increase
33 dition, FGF-21 knockdown reduced lithium-VPA co-treatment-induced Akt-1 activation and neuroprotectio
34 l gastric cancer xenograft mouse model, drug co-treatments led to increased mouse survival as well as
37 Taken together, these findings suggest that CO treatment may provide a therapeutic approach for TBI
38 tic testing for STDs have changed over time, co-treatment may no longer be needed as a clinical or pu
40 nic lymphocytic leukemia cells revealed that co-treatment of 1alpha,25-dihydroxyvitamin D3 plus inhib
43 metformin induced PIM-2 kinase activity and co-treatment of ALL cells with a PIM-1/2 kinase inhibito
44 4HPR-induced apoptosis was unaffected by co-treatment of both cell lines with equimolar RAR antag
51 h the peptide iRGD, as well as the effect of co-treatment of DOX and iRGD on tumor weight and cell de
73 rcome by low concentrations of estrogen in a co-treatment paradigm with high ICI levels indicating th
74 en was added at the same time as the AI in a co-treatment paradigm, normal developmental appearance o
81 nclude that chronic lumacaftor and ivacaftor co-treatment restores stability in a small subpopulation
83 n the absence of radiation exposure, and LPS co-treatment significantly affected their radiation resp
95 istant to paclitaxel and are resensitized by co-treatment with ABT-737, a BH3-mimetic small molecule
100 optosis in fetal rhombencephalic neurons and co-treatment with alpha-lipoic acid (LA) or one of sever
109 response, which was partially protected via co-treatment with beta-mercaptoethanol, resulting in red
115 er reduction of photoreceptor cell demise by co-treatment with calpastatin and salubrinal suggests co
117 rboplatin enriches for CA125-negative cells, co-treatment with carboplatin and birinapant eliminates
122 s with various forms of viral immunogens and co-treatment with cytokines and chemokines is being used
123 proteins and receptors and was inhibited by co-treatment with Dickkopf-related protein-1, an extrace
124 activity against such tumors is augmented by co-treatment with differentiation-inducing agents such a
125 of intracellular thiols by diethylmaleate or co-treatment with dithiothreitol decreased the accumulat
126 tosis alone, they can often be sensitized by co-treatment with DNA-damaging agents such as etoposide.
130 rs, BMP4-induced cell death was prevented by co-treatment with either neurotrophin-3 (NT-3) or nerve
132 The extent of apoptosis is increased by co-treatment with either the protein synthesis inhibitor
137 bited receptor tyrosine phosphorylation, and co-treatment with FTI-277 had no additional effect.
140 s observed to block MAPK activation by PDGF, co-treatment with GGOH, but not FOH, restored its activa
141 cked PDGF receptor tyrosine phosphorylation, co-treatment with GGOH, but not FOH, reversed the lovast
143 -hexose cell content which was suppressed by co-treatment with glycogen synthase kinase 3 inhibitor S
145 t vincristine markedly decreased CAT levels; co-treatment with HGF and CNTF (but not either factor al
146 genic MAPK signaling increased ETC activity, co-treatment with HKL ablated this response and vastly e
147 sufficient to phenocopy cry1 seedlings, but co-treatment with IAA plus GA4 produced cry1-like growth
150 This effect of TGF-beta1 was prevented by co-treatment with IGFBP-3-neutralizing antibodies or IGF
157 RNA was selectively and markedly elevated by co-treatment with lithium and VPA in primary rat brain n
158 n collagen synthesis, which was abrogated by co-treatment with losartan (an AT-1R antagonist), wortma
159 ase in PI3K activity, which was abolished by co-treatment with losartan or 2',5'-dideoxyadenosine (2'
166 APP protein, soluble APP, and APLP2, whereas co-treatment with mecamylamine (an antagonist of nicotin
167 ed neuronal cell death that was prevented by co-treatment with MIP-1alpha, suggesting that this endog
168 antly increased MUC5AC-luc activity, whereas co-treatment with mithramycin A, a Sp1 inhibitor, abolis
170 lation of MIP-1 alpha mRNA was suppressed by co-treatment with N-acetylcysteine, a synthetic antioxid
175 ncrease in PI3K activity was also blocked by co-treatment with PP2, an Src inhibitor, or AG1478, an e
176 of the NF-kappaB target IL-8 was blocked by co-treatment with PPARgamma agonists, and direct inhibit
179 oxide insult resulted in 85% cell death, but co-treatment with pyruvate dose-dependently attenuated c
181 r (PXR)-humanized mouse model, we found that co-treatment with RIF and INH causes accumulation of the
189 rease in CAR association with the OARE after co-treatment with TCPOBOP and OA, indicating the indirec
190 5) M), induced apoptosis that was blocked by co-treatment with the antiprogestin but enhanced by co-t
191 tralizing this second mode of action through co-treatment with the beta-blocker propranolol, while le
193 2F1-dependent dormancy is recapitulated by a co-treatment with the DNA-demethylating agent 5-Aza-C an
194 OR-P labeling was dose-dependent, blocked by co-treatment with the kappa antagonist norbinaltorphimin
196 ionophore-mediated increase, was blocked by co-treatment with the mitogen-activated protein (MAP) ki
197 o glutamate-induced excitotoxicity, and that co-treatment with the mood stabilizers lithium and valpr
199 In addition, in the face of NOS blockade, co-treatment with the NO donor sodium nitroprusside or t
200 AR phosphorylation was completely blocked by co-treatment with the PKC inhibitor, bisindolylmaleimide
201 ased c-Myc degradation, which was reduced by co-treatment with the proteasomal inhibitor, MG-132.
205 in WT vs. CD-WT mice, which was prevented by co-treatment with the reactive oxygen species scavenger
209 nto the mechanism of liver injury induced by co-treatment with these compounds and may lead to their
210 nduced apoptotic cell shape changes, whereas co-treatment with this antibody plus V(+)H(+) reversed t
217 trations were equally protective and whether CO treatment would be effective in a large animal specie
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。